Dear Reader,
The FDA has started to quietly send out a signal …
That has given investors a 97% chance of making money.
For an average gain of 117% in eight months.
Some of the gains have been even more extraordinary …
Take Adaptimmune Therapeutics, for example.
Shares were hovering around one dollar when the FDA sent out this quiet signal on their new tumor drug.
Within six months, shares shot up 845% …
Caladrius Biosciences’ stock was going nowhere, stuck around $4 …
Then it got this FDA signal.
And shares jumped 119% — in two days.
Ocugen received an FDA signal in December 2023.
Its share price spiked 435% in just five months.
63 different publicly traded companies have received 76 of these signals between them in the last seven years.
We examined every single one.
97% of them saw the stock price go up in the aftermath.
And now, we believe the next FDA signal could come any day …
Perhaps as soon as 9:30 a.m. tomorrow.
Click here to find out how you can get in before the FDA’s potential signal.
Sincerely,
Michael Robinson, Editor
Disruptors & Dominators
